Cingulate Director Receives 15,000 Stock Options at $4.14 Strike Price
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Director Jeffrey S. Ervin of Cingulate has been granted 15,000 stock options on June 20, 2025. The options have the following key terms:
- Exercise price set at $4.14 per share
- Expiration date of June 20, 2035 (10-year term)
- Vesting occurs at the earlier of:
- One-year anniversary of grant date
- Date of Cingulate's 2026 annual stockholder meeting
This Form 4 filing represents a standard director compensation grant, with the options providing Ervin the right to purchase common stock at the specified strike price. The grant aligns the director's interests with shareholders through long-term equity incentives.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) | 15,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2026 annual meeting of stockholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Jeffrey Ervin receive from CINGW on June 20, 2025?
When do Jeffrey Ervin's CINGW stock options vest?
What is Jeffrey Ervin's role at CINGW?
What was the total value of stock options granted to Jeffrey Ervin in this Form 4 filing?
Who signed this Form 4 filing for CINGW?
AI-generated analysis. How Rhea-AI works. Not financial advice.